Last updated 2026-07-20
- Raised Undisclosed Round led by Fundit, Nov 2019
Total raised
—
Last: Undisclosed Round 2019-12
Stage
Seed
Founded
—
Headcount
3
HQ
Meishar, Israel
Sector
Health Tech & Life Sciences
About
DUN T1 is an early-stage R&D company that develops an orally administered drug for type 1 diabetes. DUN T1's vision is to develop a proactive approach towards treatment and early diagnosis. DUN T1's novel natural ingredient is patented, safe, and effective.
Funding history · 1 round · — total
2019-11
Undisclosed Round
Undisclosed
★ Fundit
Headcount over time
From 2 (2019-06) to 3 (2023-01) · +1 (+50%) · 4 points · source: Finder history + radar grounding
Q&A
- What is DUN T1's primary focus?
- DUN T1 is an early-stage R&D company developing an orally administered drug for type 1 diabetes, aiming for a proactive approach to treatment and early diagnosis.
- When was DUN T1 founded?
- DUN T1 was founded in July 2017.
- How much funding has DUN T1 raised to date?
- DUN T1 has raised a total of $45,000 USD.
- When was DUN T1's last funding round and who invested?
- DUN T1's last funding round was in December 2019, with investment from Fundit.
- Does DUN T1 hold any patents?
- Yes, DUN T1 holds one patent for its novel natural ingredient.
- Who are the founders of DUN T1?
- The founders of DUN T1 are Daniella Givon (CEO & Head of R&D), Raanan Margalit (Head of Pre-Clinical Studies), and Nadav Shraibom (Head of Strategy Affairs).
- What is DUN T1's current product stage?
- DUN T1's product is currently in the R&D stage.
Team · 3
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Target customers
Commerce & RetailDistribution ChannelsDistributorHealthcare & Life SciencesLife SciencesPharmaceuticalsHealthcarePatients
Business model
B2B2C
Highlights
1 Patents
Tags
patientschildrenpharma-companiespharmaceuticalsdrug-discoverychronic-patientschronic-diseasetreatmentsnatural-active-ingredientsdiabetesoral-drugs
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | dunica.info/ |
|---|---|
| linkedin.com/company/18844730 | |
| YouTube | youtube.com/channel/UC2AMbPElxCcDQv5H2qLVVMA |
Identifiers & details
| Employees (exact) | 3 |
|---|
Radar intelligence
Web history (Wayback)
| Domain | dunica.info |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516033875 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2019-06-02 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 2 — shares_capital (1), annual_report (1) |
| Registered address | הדוכיפת 34 מישר |
Recent registry events
| Date | Event |
|---|---|
| 2026-03-21 | הקצאת מניות |
| 2025-09-07 | דו~ח שנתי |